Monitoring in Chronic Disease

[1]  Sean Keenan,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.

[2]  F. Cappuccio,et al.  Blood pressure control by home monitoring: meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[3]  C. Cooper,et al.  The role of long-acting bronchodilators in the management of stable COPD. , 2004, Chest.

[4]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[5]  R E Ferner,et al.  Joining the DoTS: new approach to classifying adverse drug reactions , 2003, BMJ : British Medical Journal.

[6]  R. Zuwallack,et al.  Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. , 2003, Chest.

[7]  E. R. Sutherland,et al.  Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis , 2003, Thorax.

[8]  C. Strange,et al.  Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary Disease , 2003, Annals of Internal Medicine.

[9]  P. Barnes,et al.  Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? , 2003, Current opinion in pharmacology.

[10]  David W Bates,et al.  A computer-based intervention for improving the appropriateness of antiepileptic drug level monitoring. , 2003, American journal of clinical pathology.

[11]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[12]  C. van Weel,et al.  Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial , 2003, Thorax.

[13]  Abdullah Alsaeedi,et al.  The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. , 2002, The American journal of medicine.

[14]  C. Henderson,et al.  Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  D. Postma,et al.  A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. , 2002, Chest.

[16]  W. Hop,et al.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.

[17]  S. Ramsey,et al.  Suboptimal medical therapy in COPD: exploring the causes and consequences. , 2000, Chest.

[18]  C. Begg,et al.  On the use of surrogate end points in randomized trials , 2000 .

[19]  B. Lipworth.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.

[20]  P B Boggs,et al.  Using statistical process control charts for the continual improvement of asthma care. , 1999, The Joint Commission journal on quality improvement.

[21]  C. Lowy,et al.  Home glucose monitoring, who started it? , 1998, BMJ.

[22]  S. Rennard,et al.  Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. , 1996, Chest.

[23]  D. Mant,et al.  Motivational effect of cholesterol measurement in general practice health checks. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.

[24]  P. Glasziou,et al.  Estimating an individual's true cholesterol level and response to intervention. , 1991, JAMA.

[25]  G H Guyatt,et al.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. , 1990, Annals of internal medicine.

[26]  S. Carruthers,et al.  An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls. , 1983, Therapeutic drug monitoring.

[27]  R. Braithwaite,et al.  Prediction of Steady‐State Plasma Concentrations and Individual Dosage Regimens of Tricyclic Antidepressants from a Single Test Dose , 1982, Therapeutic drug monitoring.